Primer: Sinopep-Allsino Bio Pharmaceutical (688076 CH) - Aug 2026
Sinopep-Allsino is a rapidly growing contract development and manufacturing organization (CDMO) and API producer, specializing in high-growth...
105 Views
𝛼SK or SearchENTITY
Sinopep-Allsino Bio Pharmaceutical (688076 CH)
Sinopep-Allsino Bio Pharmaceutical (688076 CH)
26
Analysis
Health Care • China
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. researches, develops, manufactures, and sells peptide drugs and small molecule drugs. The Company produces liraglutide, somalutide, alogliptin benzoate, bivalirudin, eptifibatide, and more. Sinopep-Allsino Bio Pharmaceutical applies its products in treatment of diabetes, cardiovascular diseases, tumors, and other fields.
morex